Gut bacteria and energy metabolism in health and IBD
Part of Digestive system clinical trials.
This study looks at how the bacteria living in your gut affect your body's energy use. It includes both healthy volunteers and people with inactive Crohn's disease or ulcerative colitis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 49 years old.
- Your body mass index (BMI) is between 17 and 25.
- You have regular bowel movements (at least every other day, up to 3 times a day).
- If you have Crohn's or colitis, you have been in remission (no active symptoms) for at least 6 months without steroids.
- If you are a woman able to have children, you must use effective birth control.
- You have not taken antibiotics or antifungals by mouth in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how changes in gut bacteria (the microbiome) relate to inflammatory bowel disease, including ulcerative colitis and Crohn disease. It may help researchers understand what might improve symptoms or disease control.
This study follows people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who may be taking immunosuppressants (medicines that calm the immune system). Researchers will track how the disease progresses and look at factors like gut bacteria to find ways to predict complications.
This study uses breath tests to see how a special diet changes gases in your gut that might affect ulcerative colitis. It aims to find out if these changes can help manage your condition.
This study tests whether a special diet using a nutritional supplement can reduce inflammation and improve symptoms in people with active Crohn's disease affecting the small intestine. It aims to see how the diet changes gut bacteria and body composition.
This study tests if a standardized fecal transplant is safe and helpful for adults with moderately to severely active Crohn's disease who are already on maintenance therapy. The goal is to see if this treatment can reduce inflammation in the digestive tract.
This study analyzes your gut bacteria to see if it can predict how well you will respond to Crohn's disease treatments. If you are having a colonoscopy for routine care, you may be eligible.
Hear when a new IBD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.